| Literature DB >> 34249792 |
Sajida Batool1, Arvind Ahuja1, Devender Singh Chauhan1, Minakshi Bhardwaj1, Atul Kumar Meena2.
Abstract
Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory myofibroblastic tumor. It has an aggressive clinical course and a high rate of recurrence. EIMS primarily affects children and young adults. Hereby, we report this entity in a 4-month-old infant who presented with an abdominal mass. Imaging studies revealed a large hypodense mesentery-based lesion involving the right half and mid-region of the abdomen. The mass with an attached segment of the small bowel was excised in toto. Grossly, a large encapsulated tumor was identified arising from the mesentery of the small bowel. The histological examination showed a tumor consisting of epithelioid to spindle cells loosely arranged in a myxoid background with numerous blood vessels and lymphoplasmacytic inflammatory infiltrate. On immunohistochemistry, the tumor cells showed positivity for ALK1 (nuclear), desmin, SMA, CD68, and focal positivity for CD30. A final diagnosis of EIMS of the small intestine was rendered. To the best of our knowledge, this case is the youngest reported case in literature. Copyright:Entities:
Keywords: Anaplastic Lymphoma Kinase; Epithelioid Cells; Intestine, Small; Mesentery; Sarcoma
Year: 2021 PMID: 34249792 PMCID: PMC8214882 DOI: 10.4322/acr.2021.288
Source DB: PubMed Journal: Autops Case Rep ISSN: 2236-1960
Figure 1Gross examination of the tumor showing a mass with attached ileal segment and its cut surface (scale bar = 9 cm).
Figure 2Histopathological examination of the tumor. A – Moderately cellular tumor with intervening small blood vessel (H&E, x100); B – Tumor cells with moderate eosinophilic cytoplasm and oval to spindle nuclei (H&E, x200); C – Myxoid area along with mild lymphoplasmacytic inflammatory infiltrate (H&E, x200); D – Epithelioid to round cell morphology of tumor cells with conspicuous nucleoli and few binucleated forms (H&E, x400).
Antibodies used for immunohistochemical (IHC) staining and their interpretation
|
|
|
|---|---|
| Positive | ALK, SMA, CD30, CD68, and Desmin |
| Negative | Pan CK, EMA, CD34, CD117, S100, CD99, BCL2 |
| MyoD1, Myogenin |
ALK, anaplastic lymphoma kinase; BCL, B-cell lymphoma; CD, cluster of differentiation; CK, cytokeratin; EMA, epithelial membrane antigen; MyoD1, myoblast determination protein 1; SMA, smooth muscle actin; S100, solubility in 100%ammonium sulphate.
Figure 3Immunohistochemistry. A – Tumor cells showing ALK nuclear membranous positivity (inset) (x400); B – Diffuse desmin positivity (x400); C – SMA positivity (x400); D – Focal CD30 positivity (x200).
Main differential diagnoses of EIMS
|
|
|
|---|---|
| EIMS | ALK +, SMA +, EMA +/-, CK +/-, CD30 +, CD34 -, and Desmin + |
| GIST | CD117 +, DOG1 +, CD34 +, and Desmin - |
| ALCL | ALK +, SMA +, EMA +, CD30 +, and Desmin - |
| ELMS | ALK -, SMA +, EMA + and Desmin + |
| LGFMS | EMA +, MUC4 +, CD99, BCL2, SMA +/-, and Desmin +/- |
| RMS | ALK+/-, Myogenin +, MyoD1 +, Desmin +, SMA +, EMA -, CD30 - |
| MM | CK5 +, Calretinin +, EMA +/-, and Desmin - |
| Our case | ALK +, SMA +, CD30 +, CK-, EMA -, CD34 -, and Desmin + |
ALCL, anaplastic large cell lymphoma; ALK, anaplastic lymphoma kinase ; BCL, B cell lymphoma; CD, cluster of differentiation; CK, cytokeratin; DOG1, discovered on GIST 1 ; EIMS, epithelioid inflammatory myofibroblastic sarcoma; EMA, epithelial membrane antigen; ELMS, epithelioid leiomyosarcoma, ; GIST, gastrointestinal stromal tumor; LGFMS, low grade fibromyxoid sarcoma; MM, malignant mesothelioma; MUC, mucin; MyoD1, myoblast determination protein 1; RMS, rhabdomyosarcoma; SMA, smooth muscle actin.